We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+13.74%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$35.9B
AUM Growth
+$3.26B
(+10%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
23.92%
Holding
882
New
34
Increased
380
Reduced
351
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$167M |
| 2 |
First Solar
FSLR
|
+$139M |
| 3 |
Amazon
AMZN
|
+$126M |
| 4 |
ExxonMobil
XOM
|
+$124M |
| 5 |
Coca-Cola
KO
|
+$83.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$203M |
| 2 |
NVIDIA
NVDA
|
+$158M |
| 3 |
Microsoft
MSFT
|
+$144M |
| 4 |
UnitedHealth
UNH
|
+$139M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$99.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.11% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 12.63% |
| 4 | Financials | 9% |
| 5 | Industrials | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Regions Financial
RF
$26.8B
| $19.8M | 0.06% |
1,022,895
-339,687
| -25% | -$5.64M |
|
|
ANSS
302
DELISTED
Ansys
ANSS
| $19.8M | 0.06% |
54,487
-1,416
| -3% | -$419K |
|
303
Ulta Beauty
ULTA
$23.6B
| $19.6M | 0.05% |
39,981
-97,646
| -71% | -$41.2M |
|
304
Herc Holdings
HRI
$5.68B
| $19.3M | 0.05% |
129,724
+12,491
| +11% | +$1.53M |
|
305
Fortune Brands Innovations
FBIN
$5.73B
| $19.2M | 0.05% |
252,608
-42,598
| -14% | -$2.8M |
|
306
Tractor Supply
TSCO
$18B
| $18.7M | 0.05% |
434,860
-38,775
| -8% | -$1.58M |
|
307
Columbia Sportswear
COLM
$2.92B
| $18.7M | 0.05% |
234,743
+4,463
| +2% | +$340K |
|
308
Clorox
CLX
$13B
| $18.7M | 0.05% |
130,804
-129,461
| -50% | -$17.3M |
|
|
ONC
309
BeOne Medicines Ltd
ONC
$40.6B
| $18.6M | 0.05% |
102,970
+7,130
| +7% | +$1.29M |
|
310
Ormat Technologies
ORA
$6.87B
| $18.5M | 0.05% |
243,911
+223,195
| +1,077% | +$15.1M |
|
311
Zymeworks
ZYME
$1.71B
| $18.4M | 0.05% |
1,771,776
+213,525
| +14% | +$1.7M |
|
312
Labcorp
LH
$26.1B
| $18.4M | 0.05% |
80,748
-16,059
| -17% | -$3.37M |
|
313
Green Plains
GPRE
$1.06B
| $18.3M | 0.05% |
724,029
-433,435
| -37% | -$11.5M |
|
314
Molson Coors Class B
TAP
$7.93B
| $17.8M | 0.05% |
291,250
+131,841
| +83% | +$7.93M |
|
315
LKQ Corp
LKQ
$6.22B
| $17.8M | 0.05% |
371,414
-61,423
| -14% | -$2.87M |
|
316
Veralto
VLTO
$23.7B
| $17.7M | 0.05% |
+214,576
| New | +$16M |
|
317
Kosmos Energy
KOS
$1.49B
| $17.5M | 0.05% |
2,601,983
+628,691
| +32% | +$4.4M |
|
318
Globe Life
GL
$14.2B
| $17.4M | 0.05% |
142,764
+39,326
| +38% | +$4.62M |
|
319
Qorvo
QRVO
$8.56B
| $17.3M | 0.05% |
153,806
-383,735
| -71% | -$37.1M |
|
320
Kanzhun
BZ
$7.8B
| $17.3M | 0.05% |
1,040,166
+995,901
| +2,250% | +$15.6M |
|
321
Ionis Pharmaceuticals
IONS
$9.46B
| $17.2M | 0.05% |
+339,667
| New | +$16.3M |
|
322
CVS Health
CVS
$122B
| $17M | 0.05% |
215,798
-22,468
| -9% | -$1.6M |
|
323
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.18B
| $16.7M | 0.05% |
604,812
-1,470,731
| -71% | -$32M |
|
324
Realty Income
O
$58.6B
| $16.6M | 0.05% |
288,555
-28,312
| -9% | -$1.49M |
|
325
Duke Energy
DUK
$94.5B
| $16.3M | 0.05% |
168,050
+59,954
| +55% | +$5.45M |
|
Similar funds
BNP Paribas Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, BNP Paribas Asset Management held 882 positions worth $35.9B, up 10% from $32.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BNP Paribas Asset Management's Q4 2023 filing shows 34 new, 380 increased, 351 reduced and 39 closed positions. Its largest new stake was e.l.f. Beauty: 235,014 shares worth $33.9M. The largest sale was Apple, an estimated $203M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- BNP Paribas Asset Management's largest Q4 2023 buy was e.l.f. Beauty: 235,014 shares worth $33.9M.
- BNP Paribas Asset Management added most to Regeneron Pharmaceuticals in Q4 2023, an estimated $167M increase.
- BNP Paribas Asset Management's biggest Q4 2023 reduction was Apple, cutting an estimated $203M.
- BNP Paribas Asset Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $99.6M.
- BNP Paribas Asset Management's ten largest holdings make up 24% of its $35.9B portfolio in Q4 2023.
- BNP Paribas Asset Management opened 34 new positions and closed 39 in Q4 2023.
- BNP Paribas Asset Management's portfolio value rose 10% quarter-over-quarter to $35.9B.
Based on BNP Paribas Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.